Trajectory of patient outcomes for those diagnosed with bronchiectasis is explored by Dr Metersky.
This is a video synopsis/summary of an Insights involving Mark Metersky, MD, FCCP, on the prognosis of bronchiectasis.
The prognosis varies based on severity, especially if treated aggressively early on. With treatment, most patients can have a normal life expectancy, though slow symptom progression often occurs. At initial evaluation, patients are counseled that bronchiectasis will likely persist lifelong as an annoyance rather than severely limiting. Evidence supports improved quality of life with specialty center care, though high-quality generalist care can replicate good outcomes.
The bronchiectasis severity index stratifies prognosis based on multiple factors like age, comorbidities, lung function, and chronic bacterial airway infection. Most patients have nonsevere disease without dramatically shortened survival. Death directly related to bronchiectasis is unusual.
Worse outcomes are predicted by chronic Pseudomonas airway infection and frequent exacerbations of 3 or more per year despite aggressive therapy. These patients tend to remain frequent exacerbators.
There are no FDA-approved bronchiectasis treatments. One nonapproved therapy, chronic low-dose macrolide antibiotics, can reduce exacerbation frequency, but most frequent exacerbators stay that way.
Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
Coexistence of HIV, Hemophilia May Lead to Increased Presence of Coronary Artery Stenosis
May 8th 2024In patients living with HIV, the cardiovascular risk factors that come with infection may lead to an increased prevalence of coronary artery stenosis, especially in those who also have hemophilia.
Read More
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More